Laporte, Amandine
Mariampillai, Kubéraka
Allenbach, Yves
Pasi, Nicoletta
Donciu, Victoria
Toledano, Dan
Granger, Benjamin
Benveniste, Olivier
Grenier, Philippe A.
Boussouar, Samia
Article History
Received: 21 April 2021
Revised: 4 October 2021
Accepted: 13 October 2021
First Online: 13 January 2022
Declarations
:
: The scientific guarantor of this publication is Dr. Boussouar Samia.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: Dr. Mariampillai Kubéraka kindly provided statistical advice for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in “Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies.” <i>JAMA Neurology</i> 2018.
: • retrospective• cross sectional study / diagnostic study / observational• performed at one institution